Do not use carelessly, Azithromycin is not recommended for patients with mild symptoms

Tribunnews.com Reporter, Rina Ayu

TRIBUNNEWS.COM, JAKARTA – A number of professional organizations have proposed revisions to the protocol for the management of Covid-19.

One of them is removing the drug Azithromisin and Oseltamivir which is no longer the standard of care for Covid-19 patients

Experts from Indonesian Doctors Association (IDI) Prof. Zubairi Djoerban said the revision of usage Oseltamivir and Azithromisin also performed by the WHO.

“Actually, Oseltamivir is a good drug. This antiviral drug is used to treat Influenza infections in the body. Not for Covid-19. So it is clear, in principle, Oseltamivir is not a Covid-19 drug,” he said as quoted from his Twitter account, Monday (19/7). /2021).

Also read: Stop Using Ivermectin for Children in Covid-19 Therapy

While Azithromisin is an antibiotic drug that treats bacteria.

“Covid-19 is the cause of the virus. So, Covid-19 patients should not be given Azithromisin unless there is a secondary bacterial infection. However, its use is still determined by the doctor,” explained the Head of the IDI Covid-19 Task Force.

Side Effects of Use Azithromisin

He revealed that the revision was carried out because several studies revealed that the impact of Azithromisin against Covid-19 patients it is not effective.

Even its use unnecessarily makes the patient susceptible to the side effects of the drug. One of them increases the risk of resistance.

–